阿维A治疗一名9岁女童的变异性红斑角化病
Acitretin for erythrokeratodermia variabilis in a 9-year-old girl.
作者信息
Graham-Brown Robin A C, Chave Toby A
机构信息
Department of Dermatology, Leicester Royal Infirmary, Leicester, United Kingdom.
出版信息
Pediatr Dermatol. 2002 Nov-Dec;19(6):510-2. doi: 10.1046/j.1525-1470.2002.00221.x.
Abstract
Erythrokeratodermia variabilis (EKV) is a rare genodermatosis with a unique phenotype. Treatment with oral synthetic retinoids is well documented in adults, but not in children. We report a 9-year-old girl with EKV who cleared rapidly following treatment with oral acitretin.
摘要
可变型红斑角化病（EKV）是一种具有独特表型的罕见遗传性皮肤病。口服合成维甲酸治疗在成人中有充分记录，但在儿童中则不然。我们报告了一名9岁患可变型红斑角化病的女孩，口服阿维A治疗后迅速痊愈。
Zotero 插件